Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2241
https://www.valueinhealthjournal.com/article/S1098-3015(16)33607-5/fulltext
Title :
Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33607-5&doi=10.1016/j.jval.2016.09.2241
First page :
A738
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2124